These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

483 related articles for article (PubMed ID: 16835077)

  • 41. Hormone replacement therapy in breast cancer survivors.
    Xydakis AM; Sakkas EG; Mastorakos G
    Ann N Y Acad Sci; 2006 Dec; 1092():349-60. PubMed ID: 17308160
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Rationale for low-dose systemic hormone replacement therapy and review of estradiol 0.5 mg/NETA 0.1 mg.
    Johansen OE; Qvigstad E
    Adv Ther; 2008 Jun; 25(6):525-51. PubMed ID: 18568306
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Estrogen excretion during testosterone and progestagen therapy of dysfunctional climacteric hemorrhage].
    Aronovich AS; Manuilova IA
    Sov Med; 1969 Aug; 32(8):14-7. PubMed ID: 5381914
    [No Abstract]   [Full Text] [Related]  

  • 44. [Quality of life from estrogen].
    Rutanen EM
    Duodecim; 2003; 119(22):2217-23. PubMed ID: 14702811
    [No Abstract]   [Full Text] [Related]  

  • 45. Hormones for improved sexuality in the male and female climacteric.
    Greenblatt RB; Witherington R; Sipahioglu IB
    Drug Ther (NY); 1976 Sep; 6():101-4. PubMed ID: 12259609
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Menopausal symptom perception and severity: results from a screening questionnaire.
    Berg JA; Larson CA; Pasvogel AE
    J Clin Nurs; 2008 Apr; 17(7):940-8. PubMed ID: 18321291
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Depressive symptoms, menopausal status, and climacteric symptoms in women at midlife.
    Bosworth HB; Bastian LA; Kuchibhatla MN; Steffens DC; McBride CM; Skinner CS; Rimer BK; Siegler IC
    Psychosom Med; 2001; 63(4):603-8. PubMed ID: 11485114
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The hot flush: the enigma of the climacteric.
    Sturdee DW
    Climacteric; 2001 Mar; 4(1):1-3. PubMed ID: 11379372
    [No Abstract]   [Full Text] [Related]  

  • 49. [The significance of progesterone and gestagens in climacteric].
    Gruber DM; Wieser F; Sator M; Huber JC
    Zentralbl Gynakol; 1997; 119 Suppl 2():34-7. PubMed ID: 9441541
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Efficacy and tolerability of continuous combined hormone replacement therapy in early postmenopausal women.
    Mattsson LA; Skouby S; Rees M; Heikkinen J; Kudela M; Stadnicki-Kolendo A; Mattila L; Salminen K; Vuorela A; Mustonen M;
    Menopause Int; 2007 Sep; 13(3):124-31. PubMed ID: 17785038
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Postmenopausal hormone therapy and the risk of cardiovascular disease.
    Stramba-Badiale M
    J Cardiovasc Med (Hagerstown); 2009 Apr; 10(4):303-9. PubMed ID: 19430340
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Psychosocial aspects of the change of life].
    Buddeberg C
    Ther Umsch; 2000 Oct; 57(10):600-3. PubMed ID: 11081370
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Differentiated therapy of the climacteric syndrome].
    Huber J
    Wien Med Wochenschr; 1992; 142(5-6):124-6. PubMed ID: 1615681
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Regular exercise reduces the climacteric problems].
    Hammar M
    Lakartidningen; 2004 May; 101(21-22):1896-901. PubMed ID: 15190754
    [No Abstract]   [Full Text] [Related]  

  • 55. [Psycho-organic comorbidity of climacteric: acknowledgement of denial].
    Souza y Machorro M
    Ginecol Obstet Mex; 2002 Mar; 70():118-29. PubMed ID: 12017957
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Hormone replacement therapy and cardiovascular prevention. Where are we now?].
    Lerman J; Siseles N
    Medicina (B Aires); 2008; 68(3):251-7. PubMed ID: 18689159
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Subdermal implantation of estradiol 17 beta (25 mg) in hysterectomized and ovariectomized women. Effects of increased serum estradiol level and neurovegetative climacteric complaints].
    Tsvetkov Ts; Tsvetkov K; Petkova U
    Akush Ginekol (Sofiia); 2001; 41 Suppl 4():11-2. PubMed ID: 11519312
    [No Abstract]   [Full Text] [Related]  

  • 58. [Equine estrogens vs. esterified estrogens in the climacteric and menopause. The controversy arrives in Mexico].
    Velasco-Murillo V
    Gac Med Mex; 2001; 137(3):237-42. PubMed ID: 11432092
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Efficacy comparison of Pueraria mirifica (PM) against conjugated equine estrogen (CEE) with/without medroxyprogesterone acetate (MPA) in the treatment of climacteric symptoms in perimenopausal women: phase III study.
    Chandeying V; Sangthawan M
    J Med Assoc Thai; 2007 Sep; 90(9):1720-6. PubMed ID: 17957910
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Hormone therapy and breast cancer risk.
    Foidart JM; Desreux J; Pintiaux A; Gompel A
    Climacteric; 2007 Oct; 10 Suppl 2():54-61. PubMed ID: 17882674
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.